New Trial Will Analyze Drug’s Effect on Severe COVID-19 Patients

A lab technician begins semi-automated testing for COVID-19 at Northwell Health Labs in Lake Success, New York on March 11, 2020. Andrew Theodorakis/Getty Images

A newly announced trial will analyze the effects of an existing drug on patients with severe cases of COVID-19, the disease caused by the new coronavirus from China.

Sanofi and Regeneron Pharmaceuticals announced the trial of Kevzara, or sarilumab, on patients hospitalized with severe COVID-19.